1369 related articles for article (PubMed ID: 17717217)
1. The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations.
Stehr SN; Christ T; Rasche B; Rasche S; Wettwer E; Deussen A; Ravens U; Koch T; Hübler M
Anesth Analg; 2007 Sep; 105(3):641-7. PubMed ID: 17717217
[TBL] [Abstract][Full Text] [Related]
2. Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships.
Givertz MM; Andreou C; Conrad CH; Colucci WS
Circulation; 2007 Mar; 115(10):1218-24. PubMed ID: 17339544
[TBL] [Abstract][Full Text] [Related]
3. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
Pagel PS; Harkin CP; Hettrick DA; Warltier DC
J Pharmacol Exp Ther; 1995 Oct; 275(1):127-35. PubMed ID: 7562540
[TBL] [Abstract][Full Text] [Related]
4. Positive inotropic effect of levosimendan is correlated to its stereoselective Ca2+-sensitizing effect but not to stereoselective phosphodiesterase inhibition.
Kaheinen P; Pollesello P; Hertelendi Z; Borbély A; Szilágyi S; Nissinen E; Haikala H; Papp Z
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):74-8. PubMed ID: 16433895
[TBL] [Abstract][Full Text] [Related]
5. Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3(2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs.
Ishimori T; Gotanda K; Sasaki T; Shinbo A; Asano H; Miyazawa K; Miyasaka K
Arzneimittelforschung; 1994 May; 44(5):583-8. PubMed ID: 7912931
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of the contractile effects of levosimendan in the mammalian heart.
Bokník P; Neumann J; Kaspareit G; Schmitz W; Scholz H; Vahlensieck U; Zimmermann N
J Pharmacol Exp Ther; 1997 Jan; 280(1):277-83. PubMed ID: 8996207
[TBL] [Abstract][Full Text] [Related]
7. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B
Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
[TBL] [Abstract][Full Text] [Related]
8. A dose-response study of levosimendan in a porcine model of acute ischaemic heart failure.
Kolseth SM; Wahba A; Kirkeby-Garstad I; Aro S; Nordgaard H; Høydal M; Rognmo Ø; Nordhaug D
Eur J Cardiothorac Surg; 2012 Jun; 41(6):1377-83. PubMed ID: 22219475
[TBL] [Abstract][Full Text] [Related]
9. Influence of temperature on the positive inotropic effect of levosimendan, dobutamine and milrinone.
Rieg AD; Schroth SC; Grottke O; Hein M; Ackermann D; Rossaint R; Schälte G
Eur J Anaesthesiol; 2009 Nov; 26(11):946-53. PubMed ID: 19687740
[TBL] [Abstract][Full Text] [Related]
10. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan.
Haikala H; Kaheinen P; Levijoki J; Lindén IB
Cardiovasc Res; 1997 Jun; 34(3):536-46. PubMed ID: 9231037
[TBL] [Abstract][Full Text] [Related]
11. The effects of isosteviol against myocardium injury induced by ischaemia-reperfusion in the isolated guinea pig heart.
Xu D; Zhang S; Foster DJ; Wang J
Clin Exp Pharmacol Physiol; 2007; 34(5-6):488-93. PubMed ID: 17439420
[TBL] [Abstract][Full Text] [Related]
12. Effects of levosimendan on right ventricular function and ventriculovascular coupling in open chest pigs.
Leather HA; Ver Eycken K; Segers P; Herijgers P; Vandermeersch E; Wouters PF
Crit Care Med; 2003 Sep; 31(9):2339-43. PubMed ID: 14501965
[TBL] [Abstract][Full Text] [Related]
13. The effect of levosimendan during long-term amiodarone treatment in dogs.
Papp JG; Pollesello P; Varró A; Végh A; Udvary E
Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):27-32. PubMed ID: 16867167
[TBL] [Abstract][Full Text] [Related]
14. Effects of calcium sensitizers on intracellular calcium handling and myocardial energetics.
Hasenfuss G; Pieske B; Kretschmann B; Holubarsch C; Alpert NR; Just H
J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S45-51. PubMed ID: 8907130
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
[TBL] [Abstract][Full Text] [Related]
16. Effects of levosimendan on myocardial contractility and oxygen consumption.
Todaka K; Wang J; Yi GH; Stennett R; Knecht M; Packer M; Burkhoff D
J Pharmacol Exp Ther; 1996 Oct; 279(1):120-7. PubMed ID: 8858984
[TBL] [Abstract][Full Text] [Related]
17. TMB-8 as a pharmacologic tool in guinea pig myocardial tissues. I. Effects of TMB-8 on force of contraction and on action potential parameters in atrial and papillary muscles.
Himmel HM; Ravens U
J Pharmacol Exp Ther; 1990 Oct; 255(1):293-9. PubMed ID: 1698970
[TBL] [Abstract][Full Text] [Related]
18. Integrated pharmacokinetics and pharmacodynamics of the novel calcium sensitizer levosimendan as assessed by systolic time intervals.
Sundberg S; Antila S; Scheinin H; Häyhä M; Virtanen M; Lehtonen L
Int J Clin Pharmacol Ther; 1998 Dec; 36(12):629-35. PubMed ID: 9876999
[TBL] [Abstract][Full Text] [Related]
19. Myocardial accumulation of bupivacaine and ropivacaine is associated with reversible effects on mitochondria and reduced myocardial function.
Hiller N; Mirtschink P; Merkel C; Knels L; Oertel R; Christ T; Deussen A; Koch T; Stehr SN
Anesth Analg; 2013 Jan; 116(1):83-92. PubMed ID: 23223114
[TBL] [Abstract][Full Text] [Related]
20. Insulin effects on myocardial function and bioenergetics in L-bupivacaine toxicity in the isolated rat heart.
Stehr SN; Pexa A; Hannack S; Heintz A; Heller AR; Deussen A; Koch T; Hübler M
Eur J Anaesthesiol; 2007 Apr; 24(4):340-6. PubMed ID: 17241497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
